Enterprise stents for the treatment of symptomatic non-acute intracranial artery stenosis disease: safety and efficiency evaluation

Li Ma,He Zhang,Guangxin Duan,Yun Luo,Xi Zhang,Zhengjuan Lu,Zhibin Chen,Linjie Yu,Tingzheng Zhang,Yun Xu,Jingwei Li
DOI: https://doi.org/10.1080/01616412.2024.2337518
2024-04-03
Neurological Research
Abstract:Background Enterprise stent was approved for the treatment of wide-necked intracranial aneurysms. However, it has been widely used in the endovascular treatment of intracranial artery stenosis, which is still controversial. The purpose of this study was to evaluate the safety and efficiency of the Enterprise stent in the endovascular treatment of intracranial artery stenosis disease.
neurosciences,clinical neurology
What problem does this paper attempt to address?